MTPConnect is a not-for-profit organisation aiming to accelerate the rate of growth of the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia.
Formed in December 2015 as part of the Federal Government’s Industry Growth Centres Initiative, MTPConnect is an independent, not-for-profit organisation. MTPConnect is forging stronger connections between research and industry to help maximise opportunities for Australians to not only make scientific and technological breakthroughs, but to see them developed through the proof-of-concept stage and successfully translated and commercialised. In this way, MTPConnect is building a more resilient and competitive medical products sector.
MTPConnect raises awareness, fosters collaboration and competition, aggregates existing knowledge and shares it with the broader MTP sector. It also jointly funds projects that address the Sector Growth Priorities and the constraints and gaps identified in the sector.
MTPConnect's mandate as an Industry Growth Centre is focused on four key areas:
- Increasing collaboration and commercialisation across the sector
- Improving management and workforce skills
- Improving access to global supply chains and international markets
- Optimising the regulatory environment
The MTPConnect Head Office is located at Level 1, Suite 1.01, 250 Bay Street, Brighton, Victoria. MTPConnect has established key hubs at the University of Adelaide in Adelaide within Adelaide BioMed City, the Harry Perkins Institute of Medical Research in Perth and the Translational Research Institute in Brisbane. The MTPConnect Board is led by Sue MacLeman and includes other respected industry leaders.